Showing results (51-60 of 577) with videos related to
Sort By:
Pageof 58
Cell Cycle (Georgetown, Tex.)|May 18, 2012
Preferential killing of p53-deficient cancer cells by reversineMohamed Jemaà, Lorenzo Galluzzi, Oliver Kepp, et al.Molecular & Cellular Oncology|June 17, 2016
Trial watch - inhibiting PARP enzymes for anticancer therapyAntonella Sistigu, Gwenola Manic, Florine Obrist, et al.Trends in Immunology|October 28, 2022
Calreticulin surface presentation can promote quality control of hematopoietic stem cellsLorenzo Galluzzi, Guido KroemerOncoimmunology|January 28, 2025
Paradoxical control of multifocal mammary oncogenesis by radiation therapyLorenzo Galluzzi, Aitziber BuquéCell Research|September 21, 2016
Aberrant ketolysis fuels hepatocellular cancer progressionLorenzo Galluzzi, Guido KroemerJournal of Biomolecular Screening|July 15, 2003
Amplified detection of transcriptional and translational inhibitors in bioluminescent Escherichia coli K-12Lorenzo Galluzzi, Matti KarpCell Reports. Medicine|November 18, 2020
Senescence Inflames the Pancreatic Tumor MicroenvironmentGiulia Petroni, Lorenzo GalluzziTrends in Cancer|November 29, 2021
Multimodal immunostimulation to control BRCA1-defective ovarian carcinomaVanessa Klapp, Lorenzo GalluzziOncoimmunology|July 4, 2015
Combinatorial immunotherapy with checkpoint blockers solves the problem of metastatic melanoma-An exclamation sign with a question markGuido Kroemer, Lorenzo GalluzziOncoimmunology|July 9, 2015
Immunotherapy of hematological cancers: PD-1 blockade for the treatment of Hodgkin's lymphomaGuido Kroemer, Lorenzo GalluzziPageof 58